Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women

Army Medical University of People's Liberation Army

Status: Unknown

Conditions: Neonatal Alloimmune Thrombocytopenia

Treatments: Procedure: Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion

Study type: Observational

Funder types: Other

Identifiers

NCT02934906

V2.0(20160720)

Details and patient eligibility

About

This clinical study aims to investigate the anti-HPA antibodies caused neonatal alloimmune thrombocytopenia in Chinese pregnant women. The survey and data collect will help form an appropriate clinical screening procedure

Enrollment: 55,497 estimated patients

Sex: Female

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 12-28 weeks pregnant Chinese women
• between Jan 1, 2017 and Dec 31, 2018

Exclusion criteria

• Not willing to participate in this study
• Plan to terminate pregnancy early

Trial design

55,497 participants in 2 patient groups

Control Group

Description:

Pregnant women with anti-HPA antibody negative from the same hospital, the same race, and the same gravidity and parity, who are admitted at the same time.

Treatment:

Procedure: Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion

Experimental Group

Description:

pregnant women with anti-HPA antibody positive

Treatment:

Procedure: Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion